Efficient no-code solution with its own IDE for easier development.

These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...

A SimpleHelp authentication flaw is being exploited to deploy Djinn Stealer, a cross-platform malware targeting cloud, ...

We asked startup founders, recruiters, and hiring managers what to do — and not to do — to boost your chances of getting an offer.

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food ...

The AWS SDK for JavaScript v3 is a rewrite of v2 with some great new features. As with version 2, it enables you to easily work with Amazon Web Services, but has a modular architecture with a separate ...

Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmission possible. REPL's cash runway stands at under a year; workforce cuts and RP1 discontinuation are ...